Evidence mapPaperPMID 42110405Full record

ArticleFrontiers in medicine2026

A rare case of adenoma of the nonpigmented ciliary epithelium managed with a triple procedure: a case report.

Yangyang Jin, Lujia Zhou, Qiuyang Zhang, Xiangzhong Xu, Xiyan Ding

Abstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yangyang Jin *The Affiliated Eye Hospital of Nanjing Medical University, Nanjing, China.
Lujia Zhou *The Affiliated Eye Hospital of Nanjing Medical University, Nanjing, China.
Qiuyang ZhangThe Affiliated Eye Hospital of Nanjing Medical University, Nanjing, China.
Xiangzhong XuThe Affiliated Eye Hospital of Nanjing Medical University, Nanjing, China.
Xiyan DingThe Affiliated Eye Hospital of Nanjing Medical University, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Adenoma of the non-pigmented ciliary epithelium (ANPCE) is a rare intraocular tumor that is frequently misdiagnosed due to its concealed location and non-specific presentation. This report describes the diagnostic challenges of ANPCE and presents a novel "triple procedure" surgical approach that integrates partial lamellar sclerouvectomy (PLSU) with concurrent phacoemulsification and intraocular lens (IOL) implantation. Case presentation: A 39-year-old Asian woman presented with a two-month history of progressive visual decline in the left eye, which had been initially misdiagnosed as a cataract at a referral hospital. Slit-lamp examination revealed a mass posterior to the iris at the 10-11 o'clock position. Multimodal imaging, including ultrasound biomicroscopy (UBM) and magnetic resonance imaging (MRI), demonstrated a ciliary body lesion. An incisional biopsy with immunohistochemical analysis confirmed the diagnosis of ANPCE. The patient subsequently underwent localized tumor resection via PLSU combined with phacoemulsification and IOL implantation. Postoperatively, the best-corrected visual acuity (BCVA) improved to 20/22 (0.9), and no recurrence was observed during follow-up. Conclusion: Unexplained unilateral cataract warrants meticulous slit-lamp and UBM evaluation to exclude occult ciliary body tumors. A staged diagnostic approach may reduce iatrogenic risk, while a triple procedure can achieve complete tumor clearance and restore visual function.

Indexed as

adenoma of the non-pigmented ciliary epitheliumcase reportdiagnosissurgical managementtriple procedure

Identifiers

PMID42110405
PMCPMC13149164

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.